Recovery Rheum

Recovery Rheum John D. Carter, MD provides comprehensive rheumatology care for those with autoimmune & inflammatory conditions.

He is a multiple year winner of Tampa’s Best Doctors, Castle Connolly and multiple other patient care awards Carter, MD provides extensive care for those suffering from rheumatic diseases and conditions, including Rheumatoid arthritis, Systemic Lupus Erythematosis (Lupus), Psoriatic arthritis, Ankylosing spondylitis, Inflammatory bowel disease-related arthritis, Non-Radiographic Spondyloarthitis,

Gout, Giant cell arteritis (Temporal Arteritis), and Polymyalgia Rheumatica. Prior to Recovery Rheum LLC, Dr. Carter was the former Chief of Rheumatology at USF and Tampa General Hospital for 17 years.

05/13/2026

Traditional immunosuppressive therapies remain critically important in autoimmune disease. Emerging areas of research—including peptides and cellular signaling—may help us better understand future approaches to immune modulation.

05/10/2026

Pelvic floor weakness after pregnancy is incredibly common—but many women think they just have to “live with it.”

HIFEM (high frequency electromagnetic) chair technology stimulates powerful pelvic floor contractions designed to improve muscle strength and support. Clinical studies have shown improvements in stress and mixed urinary incontinence symptoms. It can also be especially helpful for recent post-partum women working to rebuild pelvic floor strength and core stability after childbirth.

Non-invasive. No downtime. Real recovery.

05/08/2026

Peptides are no longer just a trend—they’re the new era of biohacking 🧬✨ From skin barrier repair to muscle recovery, the 2026 peptide gold rush is all about cellular optimization, not just quick fixes 🧠💉 Expect major regulatory shifts and personalized, physician-guided protocols for ultimate longevity 📈🔒

05/03/2026

Struggling with chronic pain that just won’t go away? 📉 It might be time to try Focused Shockwave Therapy (FSWT). Unlike radial shockwave, FSWT penetrates deeper to hit the exact source of your pain.

🎯Why it’s a game-changer:
⚡️ Stimulates natural healing & tissue regeneration.
⚡️ Reduces inflammation and breaks down calcifications.
⚡️ Non-invasive = No surgery, no downtime.

Real Data: A 2026 study found that FSWT provided a 45% reduction in knee osteoarthritis pain compared to 18% with standard PT alone.

Ready to get moving again? Book your appointment today.

05/01/2026

Thymosin Alpha-1 (TA-1) is a naturally occurring immune peptide with real human data.

In its synthetic form (thymalfasin), it’s been used in infections, cancer, and immune dysfunction—with a strong safety profile.

Unlike many peptides, this one isn’t just theoretical.

It may help normalize immune function—not just suppress it.

The question now:

Can it be repurposed for autoimmune disease?

04/29/2026

KPV is a 3–amino acid peptide derived from alpha-MSH with anti-inflammatory effects in preclinical models (NF-κB, TNF-α, IL-6).

But here’s the reality:

We don’t have large human trials in autoimmune disease yet.

So why hasn’t it gone mainstream?

Because natural peptides like KPV are not easily patentable—limiting big pharma investment in large trials.

Where it may fit:

Early, mechanism-driven, physician-directed care—not standard of care.

The future of autoimmune treatment may be smarter regulation, not just suppression.

04/26/2026

GLP-! drugs are powerful.

But they don’t just affect appetite…

They affect reward biology.

In some patients, that may lead to a reversible anhedonia-like state.

Not proven.

But not something we should ignore.

👇

Have you experienced this?

04/25/2026

Peptides are powerful—but where you get them matters.

If a website or vial says “for research purposes only” or *“not for human use”… believe it.

Unregulated peptides may have:
• Unknown purity or contamination
• Incorrect dosing or labeling
• No sterility or safety standards

That’s not medicine—that’s risk.

Real peptide therapy should be:
✔ Physician-guided
✔ Properly dosed
✔ Sourced from a licensed compounding pharmacy designed for human use

Your body isn’t a research experiment.

04/24/2026

Peptide therapies have a promising future in medicine. However, they may not be appropriate for all individuals, particularly those with certain medical histories. Clinical evaluation and individualized care are important.

04/22/2026

A lawsuit between a major pharmaceutical company and the U.S. Food and Drug Administration could quietly reshape your access to medications for decades.

The fight?

Whether certain peptide drugs should be classified as biologics instead of drugs.

Why push for that?

Because biologics come with:

⚠️ Longer exclusivity

⚠️ Fewer competitors

⚠️ Higher barriers to generics

In other words — more control over the market.

And here’s the part most people miss:

That decision can come down to subtle molecular structure differences.

If this argument wins, it won’t just affect one drug…

It could change how an entire generation of therapies is priced, protected, and accessed.

04/19/2026

Current evidence does not demonstrate a definitive causal link between commonly discussed peptides and cancer in vitro or in vivo. However, more long-term human studies are needed to fully understand safety. Educational only. Not medical advice.

Address

2919 W. Swann Avenue, Suite 402
Tampa, FL
33609

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm

Telephone

+18136961681

Website

Alerts

Be the first to know and let us send you an email when Recovery Rheum posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category